Not all patients with CLL have to have therapy. Even with all current innovations, the iwCLL nevertheless recommends watchful observation for individuals with asymptomatic illness.86 This advice relies on no less than two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Both trials concluded https://wernerx864rzh0.salesmanwiki.com/user